AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000038 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
14
Total Shares
104,973
Total Value
$145,813.60
P&L
+inf% (+$1,838,760.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 39,394 | Direct | โ | View Details | |
Chief Financial Officer | Common stock | โ | Mar 2, 2026 | Sale | 594 | $28.96 | $17,202.24 | 38,800 | Direct | โ | View Details | |
Chief Financial Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 5,666 | $0.00 | $0.00 | 44,466 | Direct | โ | View Details | |
Chief Financial Officer | Common stock | โ | Mar 2, 2026 | Sale | 1,681 | $28.96 | $48,681.76 | 42,785 | Direct | โ | View Details | |
Chief Financial Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 46,785 | Direct | โ | View Details | |
Chief Financial Officer | Common stock | โ | Mar 2, 2026 | Sale | 1,187 | $28.96 | $34,375.52 | 45,598 | Direct | โ | View Details | |
Chief Financial Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 5,303 | $0.00 | $0.00 | 50,901 | Direct | โ | View Details | |
Chief Financial Officer | Common stock | โ | Mar 2, 2026 | Sale | 1,573 | $28.96 | $45,554.08 | 49,328 | Direct | โ | View Details | |
Chief Financial Officer | Restricted stock units | Derivative | Mar 1, 2026 | Grant/Award | 14,000 | $0.00 | $0.00 | 14,000 | Direct | โ | View Details | |
Chief Financial Officer | Stock options (right to buy) | Derivative | Mar 1, 2026 | Grant/Award | 52,000 | $0.00 | $0.00 | 52,000 | Direct | โ | View Details | |
Chief Financial Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Financial Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 5,666 | $0.00 | $0.00 | 5,667 | Direct | โ | View Details | |
Chief Financial Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 8,000 | Direct | โ | View Details | |
Chief Financial Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 5,303 | $0.00 | $0.00 | 10,607 | Direct | โ | View Details |